Asthma and influenza vaccination in elderly hospitalized patients: Matched case-control study in Spain


Por: Suárez-Varela MM, Llopis A, Fernandez-Fabrellas E, Sanz F, Perez-Lozano MJ, Martin V, Astray J, Castilla J, Egurrola M, Force L, Toledo D and Domínguez À

Publicada: 1 ene 2018 Ahead of Print: 21 jun 2017
Resumen:
Objectives: Influenza infection is an exacerbating factor for asthma, and its prevention is critical in managing asthmatic patients. We investigated the effect of influenza vaccination on asthmatic and non-asthmatic patients hospitalized with laboratory-confirmed influenza in Spain. Methods: We made a matched case-control study to assess the frequency of hospitalization for influenza in people aged >= 65 years. Hospitalized patients with unplanned hospital admissions were recruited from 20 hospitals representing seven Spanish regions. Cases were defined as those hospitalized due to a laboratory-confirmed influenza infection and controls were matched by age, sex, and hospital. Data were obtained from clinical records, and patients stratified by clinical asthma history. Vaccination status and asthma due to influenza infection were analyzed according to sociodemographic variables and medical risk conditions. Multivariable analysis was made using conditional logistic regression models. Results: 582 hospitalized patients with influenza (15.8% asthmatic) and 1,570 hospitalized patients without influenza (7.9%asthmatic) were included. In the multivariable conditional logistic regression using unvaccinated and non-asthmatic patients as the reference group, vaccination significantly prevented influenza in non-asthmatic patients (aOR = 0.63; 95% CI: 0.45, 0.88) and also showed a trend for a possibly protective effect in asthmatic patients (aOR = 0.79; 95% CI: 0.34,1.81). Conclusion: Our results suggest that influenza vaccination could be a protective factor for asthmatic patients, although the results are inconclusive and further research is required. Practically, given the better clinical evolution of vaccinated asthma cases, and the lack of better evidence, the emphasis on vaccination of this group should continue.

Filiaciones:
:
 c Centro Superior de Investigación en Salud Pública (CSISP) , Valencia , Spain

:
 c Centro Superior de Investigación en Salud Pública (CSISP) , Valencia , Spain

Fernandez-Fabrellas E:
 d Hospital General Universitario , Valencia , Spain

Sanz F:
 d Hospital General Universitario , Valencia , Spain

Perez-Lozano MJ:
 e Servicio de Medicina Preventiva , Hospital Universitario del Valme , Sevilla, Andalucia , Spain

Martin V:
 f Área de Medicina Preventiva y Salud Publica, Departamento de Ciencias Biomédicas , Universidad de León , León , Spain

Astray J:
 g Subdirección General de Epidemiologia de la Comunidad de Madrid , Madrid , Spain

Castilla J:
 h Instituto de Investigación Sanitaria de Navarra (IdiSNA) , Recinto de Complejo Hospitalario de Navarra C/Irunlarrea , Pamplona, Navarra , Spain

Egurrola M:
 i Servicio de Inmunología , Hospital de Galdakao-Usansolo , Usansolo, Vizcaya , Spain

Force L:
 j Hospital de Mataró , Mataró, Barcelona , Spain

Toledo D:
 k Departamento de Salud Pública , Universidad de Barcelona , Barcelona , Spain

Domínguez À:
 k Departamento de Salud Pública , Universidad de Barcelona , Barcelona , Spain
ISSN: 02770903





JOURNAL OF ASTHMA
Editorial
TAYLOR & FRANCIS LTD, 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND, Reino Unido
Tipo de documento: Article
Volumen: 55 Número: 4
Páginas: 391-401
WOS Id: 000428263800007
ID de PubMed: 28636411

MÉTRICAS